Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J C Mulloy

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|January 1, 1996
Insights on the pathogenicity of human T-lymphotropic/leukemia virus types I and IIA Cereseto, J C Mulloy, G Franchini
Cellular and Molecular Life Sciences : CMLS|January 20, 2009
Rac1 GTPase: a "Rac" of all tradesE E Bosco, J C Mulloy, Y Zheng
Oncogene|September 30, 2014
Posttranslational modifications of RUNX1 as potential anticancer targetsS Goyama, G Huang, M Kurokawa, et al.
The Journal of General Virology|August 1, 1995
Mapping of the intermolecular association of human T cell leukaemia/lymphotropic virus type I p12I and the vacuolar H+-ATPase 16 kDa subunit proteinI J Koralnik, J C Mulloy, T Andresson, et al.
Journal of Virology|June 1, 1996
The human T-cell leukemia/lymphotropic virus type 1 p12I proteins bind the interleukin-2 receptor beta and gammac chains and affects their expression on the cell surfaceJ C Mulloy, R W Crownley, J Fullen, et al.
Biochemical Pharmacology|October 6, 1999
Cyclic nucleotide phosphodiesterases (PDE) 3 and 4 in normal, malignant, and HTLV-I transformed human lymphocytesD Ekholm, J C Mulloy, G Gao, et al.
AIDS Research and Human Retroviruses|November 18, 2000
The MHC class I heavy chain is a common target of the small proteins encoded by the 3' end of HTLV type 1 and HTLV type 2J M Johnson, J C Mulloy, V Ciminale, et al.
Journal of Virology|July 10, 1999
A lysine-to-arginine change found in natural alleles of the human T-cell lymphotropic/leukemia virus type 1 p12(I) protein greatly influences its stabilityR Trovato, J C Mulloy, J M Johnson, et al.
Virology|August 11, 2000
The HTLV-I orfI protein is recognized by serum antibodies from naturally infected humans and experimentally infected rabbitsG A Dekaban, A A Peters, J C Mulloy, et al.
Blood|September 1, 1996
p53 functional impairment and high p21waf1/cip1 expression in human T-cell lymphotropic/leukemia virus type I-transformed T cellsA Cereseto, F Diella, J C Mulloy, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|January 1, 1996
Insights on the pathogenicity of human T-lymphotropic/leukemia virus types I and IIA Cereseto, J C Mulloy, G Franchini
Cellular and Molecular Life Sciences : CMLS|January 20, 2009
Rac1 GTPase: a "Rac" of all tradesE E Bosco, J C Mulloy, Y Zheng
Oncogene|September 30, 2014
Posttranslational modifications of RUNX1 as potential anticancer targetsS Goyama, G Huang, M Kurokawa, et al.
The Journal of General Virology|August 1, 1995
Mapping of the intermolecular association of human T cell leukaemia/lymphotropic virus type I p12I and the vacuolar H+-ATPase 16 kDa subunit proteinI J Koralnik, J C Mulloy, T Andresson, et al.
Journal of Virology|June 1, 1996
The human T-cell leukemia/lymphotropic virus type 1 p12I proteins bind the interleukin-2 receptor beta and gammac chains and affects their expression on the cell surfaceJ C Mulloy, R W Crownley, J Fullen, et al.
Biochemical Pharmacology|October 6, 1999
Cyclic nucleotide phosphodiesterases (PDE) 3 and 4 in normal, malignant, and HTLV-I transformed human lymphocytesD Ekholm, J C Mulloy, G Gao, et al.
AIDS Research and Human Retroviruses|November 18, 2000
The MHC class I heavy chain is a common target of the small proteins encoded by the 3' end of HTLV type 1 and HTLV type 2J M Johnson, J C Mulloy, V Ciminale, et al.
Journal of Virology|July 10, 1999
A lysine-to-arginine change found in natural alleles of the human T-cell lymphotropic/leukemia virus type 1 p12(I) protein greatly influences its stabilityR Trovato, J C Mulloy, J M Johnson, et al.
Virology|August 11, 2000
The HTLV-I orfI protein is recognized by serum antibodies from naturally infected humans and experimentally infected rabbitsG A Dekaban, A A Peters, J C Mulloy, et al.
Blood|September 1, 1996
p53 functional impairment and high p21waf1/cip1 expression in human T-cell lymphotropic/leukemia virus type I-transformed T cellsA Cereseto, F Diella, J C Mulloy, et al.
Pageof 3